Crinetics Pharmaceuticals Inc (CRNX) — Quality & forensics
As of 2026-11-17 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 6
- Quality 21
- Growth 69
- Balance sheet 96
- Cash quality 59
- Capital allocation 6
- Momentum 100
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — above the −1.78 threshold the literature flags for earnings-manipulation risk. A screen, not an accusation.
Continue: the CRNX chart & overview · the earnings record
FAQ · from the current data · as of 2026-11-17
Quick answers
What is Crinetics Pharmaceuticals Inc's Closelooknet quality reading?
The composite reads 50/100 across 7 modules, as of 2026-11-17: valuation 6, quality 21, growth 69, balance sheet 96, cash quality 59, capital allocation 6, momentum 100. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Crinetics Pharmaceuticals Inc's Altman Z-Score?
35.48, which sits in the safe zone (above 2.99) as of 2026-11-17. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Crinetics Pharmaceuticals Inc's Piotroski F-Score?
2 of 8, as of 2026-11-17. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Crinetics Pharmaceuticals Inc's Beneish M-Score indicate?
2.18 — above the −1.78 threshold the literature flags for earnings-manipulation risk, as of 2026-11-17. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ONC BeOne Medicines AGindustry
- REGN Regeneron Pharmaceuticals Incindustry
- ARGX.BR Argen-Xindustry
- RIGL Rigel Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- SLS Sellas Life Sciences Group Incindustry
- REPL Replimune Group Incindustry
- VCEL Vericel Corp Ordindustry
- VRDN Viridian Therapeutics Incindustry
- KOD Kodiak Sciences Incindustry
- ADMA ADMA Biologics Incindustry
- XNCR Xencor Incindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry
- MEDCL.PA Medincell SAindustry
- RPRX Royalty Pharma Plcindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- NEU.AU Neuren Pharmaceuticals Ltdindustry
- EXEL Exelixis Incindustry
- KYMR Kymera Therapeutics Incindustry